Top Page
Sinofert Holdings
(OTC:0297)
Sinofert Holdings (0297) vs. iShares MSCI Hong Kong ETF (EWH)
Sinofert Holdings Business Overview & Revenue Model
Sinofert Holdings Financial Statement Overview
| Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 21.26B | 21.73B | 23.00B | 22.64B | 21.38B |
| Gross Profit | 2.50B | 2.26B | 2.29B | 1.91B | 1.97B |
| EBITDA | 1.28B | 1.35B | 1.22B | 880.53M | 777.63M |
| Net Income | 1.06B | 625.55M | 1.12B | 866.61M | 644.07M |
Balance Sheet | |||||
| Total Assets | 21.42B | 21.98B | 20.82B | 17.49B | 17.11B |
| Cash, Cash Equivalents and Short-Term Investments | 3.81B | 3.92B | 3.36B | 1.32B | 767.21M |
| Total Debt | 1.87B | 1.83B | 1.82B | 1.09B | 1.77B |
| Total Liabilities | 10.78B | 12.06B | 11.09B | 8.51B | 8.94B |
| Stockholders Equity | 10.42B | 9.71B | 9.50B | 8.74B | 8.00B |
Cash Flow | |||||
| Free Cash Flow | 784.62M | 1.85B | 812.75M | 220.34M | 389.36M |
| Operating Cash Flow | 1.04B | 2.49B | 2.00B | 1.57B | 990.37M |
| Investing Cash Flow | -1.50B | -1.46B | -152.99M | -103.93M | -676.72M |
| Financing Cash Flow | -356.46M | -478.02M | 185.09M | -911.40M | -879.07M |
Sinofert Holdings Technical Analysis
Sinofert Holdings Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | HK$9.13B | 7.94 | 10.52% | 4.39% | -4.50% | 58.32% | |
79 Outperform | HK$7.11B | 4.26 | 17.58% | 4.96% | -3.45% | 20.63% | |
73 Outperform | HK$9.68B | 8.33 | 5.83% | 6.27% | -9.71% | -56.34% | |
69 Neutral | HK$1.06B | 11.51 | 4.75% | 2.12% | -13.75% | -56.14% | |
58 Neutral | HK$16.58B | 4.52 | -5.52% | 5.28% | -3.57% | -61.41% | |
54 Neutral | HK$1.03B | 14.10 | 2.75% | 3.42% | -11.89% | -69.45% | |
39 Underperform | HK$875.10M | ― | -81.86% | ― | -4.88% | -34.75% |
Sinofert Holdings Corporate Events
Sinofert Holdings Limited has outlined the terms of reference for its Nomination Committee, emphasizing the importance of independent non-executive directors in its governance structure. The committee is tasked with formulating nomination policies, recommending candidates for directorship, and ensuring the board’s composition aligns with the company’s corporate strategy. This move is expected to strengthen the company’s governance framework and enhance its strategic decision-making processes.
Sinofert Holdings Limited has announced the appointment of Ms. Wang Ling as a member of its Nomination Committee, effective June 24, 2025. Ms. Wang, who is also the company’s executive director and CFO, is expected to enhance the committee’s effectiveness in overseeing the nomination process and succession planning, reflecting the company’s commitment to strong corporate governance.
Sinofert Holdings Limited has announced the composition of its board of directors and the roles they will serve within the company’s various committees. This update is crucial for stakeholders as it outlines the leadership structure that will guide the company’s strategic direction, potentially impacting its market positioning and operational effectiveness.
Sinofert Holdings Limited has announced a special dividend of HK$0.0246 per share, totaling approximately HK$173 million, in celebration of its 20th anniversary of listing. This gesture is intended to express gratitude to shareholders for their long-term support, with the dividend expected to be paid by 25 July 2025. The register of members will be closed on 10 July 2025 to determine shareholder entitlement. The announcement emphasizes that this special dividend should not be seen as an indication of future dividend policies.
Sinofert Holdings Limited has announced a special cash dividend of HKD 0.0246 per share, with the ex-dividend date set for July 8, 2025, and payment scheduled for July 25, 2025. This announcement may positively impact shareholder value and reflects the company’s strong financial position, potentially enhancing its attractiveness to investors.
Sinofert Holdings Limited has announced that its board of directors will meet on June 24, 2025, to consider the proposed distribution of a special dividend. The approval of this dividend is not guaranteed, and shareholders and potential investors are advised to exercise caution when dealing with the company’s securities.
Sinofert Holdings Limited announced that all resolutions proposed at its Annual General Meeting on June 10, 2025, were passed by shareholders via poll. Key resolutions included the adoption of financial statements, approval of a final dividend, re-election of directors, and granting of mandates for share allotment and buyback. The successful passage of these resolutions reflects strong shareholder support and positions the company to continue its strategic initiatives and maintain its operational momentum.
Sinofert Holdings Limited, through its subsidiary Sinochem Changshan, has announced a new formamide production facility project with an annual capacity of 10,000 tons. This project, awarded to Luxi Industrial, is part of Sinofert’s strategy to enhance its production capabilities and explore new growth opportunities in the carbon-one chemical sector. The project, valued at up to RMB15 million, highlights Sinofert’s commitment to upgrading its operations and extending its industry chain, potentially impacting its market positioning and stakeholder interests.
Sinofert Holdings Limited has announced a final ordinary cash dividend of HKD 0.0571 per share for the financial year ending December 31, 2024. The dividend will be paid on July 25, 2025, following shareholder approval on June 10, 2025. This announcement reflects the company’s commitment to returning value to its shareholders and may positively impact investor sentiment.
Sinofert Holdings Limited has announced its upcoming annual general meeting scheduled for June 10, 2025, in Hong Kong. Key agenda items include the adoption of financial statements for 2024, approval of a final dividend, re-election of directors, and re-appointment of KPMG as auditors. Additionally, the company seeks authorization to allot and issue shares, which could impact its market operations and shareholder value.
Sinofert Holdings Limited has entered into a new Information System Services Agreement with Sinochem Information, an indirect subsidiary of its parent company, Sinochem Holdings. This agreement, effective from January 1, 2025, to December 31, 2025, encompasses a range of services including system operation and maintenance, software licensing, procurement, system improvement, and artificial intelligence services. The transactions under this agreement are classified as continuing connected transactions, subject to specific reporting and review requirements under the Hong Kong Listing Rules, but exempt from independent shareholders’ approval. This move is expected to enhance Sinofert’s operational efficiency and technological capabilities, potentially impacting its competitive positioning in the industry.
Sinofert Holdings Limited reported a turnover of approximately RMB7,167 million and a net profit of RMB519 million for the first quarter of 2025, marking a 4% increase in net profit compared to the same period in 2024. The company is committed to its ‘Bio+’ strategic transformation, which has contributed to growth in sales volume and gross profit margin by securing agricultural resource supply and supporting spring farming.
Sinofert Holdings Limited announced a connected transaction involving its subsidiary, Sinochem Yunlong, which plans to replace the bottom of a deteriorating 7000m³ initial rainwater collection tank. The company has engaged CBCF and Hebei Zhenxing through a public tender process to undertake the survey, design, procurement, and construction work for this project, valued at RMB6,616,031.66. This transaction is classified as a connected transaction under the Hong Kong Listing Rules, requiring reporting and announcement but exempt from independent shareholders’ approval. The construction is set to commence on April 18, 2025, and complete by June 16, 2025, with a two-year warranty period.